Molnupiravir for Treatment of COVID-19 in Solid Organ Transplant Recipients.
作者信息
Dhand Abhay, Okumura Kenji, Ohira Suguru, Kapur Rohan, Wolfe Kevin, Nishida Seigo
机构信息
Department of Medicine, Westchester Medical Center/New York Medical College, Valhalla, NY.
Department of Surgery, Westchester Medical Center/New York Medical College, Valhalla, NY.
出版信息
Transplantation. 2023 Jun 1;107(6):e182-e183. doi: 10.1097/TP.0000000000004588. Epub 2023 Mar 24.
Abstract
摘要
相似文献
1
Molnupiravir for Treatment of COVID-19 in Solid Organ Transplant Recipients.莫努匹拉韦用于实体器官移植受者的 COVID-19 治疗
Transplantation. 2023 Jun 1;107(6):e182-e183. doi: 10.1097/TP.0000000000004588. Epub 2023 Mar 24.
2
Real-world experience with available, outpatient COVID-19 therapies in solid organ transplant recipients during the omicron surge.奥密克戎变异株流行期间，实体器官移植受者中可获得的门诊 COVID-19 治疗的真实世界经验。
Am J Transplant. 2022 Oct;22(10):2458-2463. doi: 10.1111/ajt.17098. Epub 2022 May 30.
3
Coronavirus Disease 2019 Management Strategies in Solid Organ Transplant Recipients.《实体器官移植受者 2019 年冠状病毒病管理策略》。
Infect Dis Clin North Am. 2023 Sep;37(3):475-493. doi: 10.1016/j.idc.2023.03.003. Epub 2023 Mar 21.
4
Update on COVID-19 Therapeutics for Solid Organ Transplant Recipients, Including the Omicron Surge.COVID-19 治疗药物在实体器官移植受者中的应用进展，包括奥密克戎变异株。
Transplantation. 2022 Aug 1;106(8):1528-1537. doi: 10.1097/TP.0000000000004200. Epub 2022 Jul 22.
5
Immunosuppression in solid organ transplant recipients with Covid-19: More data, but still complicated.实体器官移植受者 COVID-19 中的免疫抑制：更多数据，但仍复杂。
Transpl Infect Dis. 2021 Aug;23(4):e13650. doi: 10.1111/tid.13650. Epub 2021 Jul 29.
6
Bebtelovimab for Treatment of COVID-19 in Ambulatory Solid Organ Transplant Recipients.贝博洛维单抗用于门诊实体器官移植受者的新冠治疗
Transplantation. 2022 Oct 1;106(10):e463-e464. doi: 10.1097/TP.0000000000004278. Epub 2022 Aug 4.
7
Molnupiravir When Used Alone Seems to Be Safe and Effective as Outpatient COVID-19 Therapy for Hemodialyzed Patients and Kidney Transplant Recipients.莫努匹韦单独使用似乎是安全有效的，可作为血液透析患者和肾移植受者的 COVID-19 门诊治疗药物。
Viruses. 2022 Oct 9;14(10):2224. doi: 10.3390/v14102224.
8
Mortality in solid organ transplant recipients with COVID-19: More than meets the eye.感染新型冠状病毒肺炎的实体器官移植受者的死亡率：表象之下另有隐情。
Am J Transplant. 2022 May;22(5):1496-1497. doi: 10.1111/ajt.16942. Epub 2022 Jan 17.
9
Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid-organ transplant recipients.解读和应对实体器官移植受者 COVID-19 疫苗接种后免疫应答不佳的问题。
J Clin Invest. 2021 Jul 15;131(14). doi: 10.1172/JCI151178.
10
A Narrative Review COVID-19 in Solid-Organ Transplantation: Real-World Evidence From India.一项关于实体器官移植中 COVID-19 的叙述性综述：来自印度的真实世界证据。
Exp Clin Transplant. 2022 Aug;20(Suppl 4):32-42. doi: 10.6002/ect.DonorSymp.2022.L21.
引用本文的文献
1
Management of concurrent severe COVID-19 pneumonia and antibody-mediated rejection following kidney transplantation: a case report.肾移植后同时发生的重症新型冠状病毒肺炎和抗体介导的排斥反应的管理：一例报告
Front Med (Lausanne). 2025 Mar 13;12:1521785. doi: 10.3389/fmed.2025.1521785. eCollection 2025.
2
Antiviral Stewardship in Transplantation.移植中的抗病毒管理
Viruses. 2024 Dec 5;16(12):1884. doi: 10.3390/v16121884.
3
Remdesivir in solid organ transplant recipients with COVID-19: a systematic review and meta-analysis.瑞德西韦用于实体器官移植受者治疗新型冠状病毒肺炎的系统评价和荟萃分析。
Clin Transplant Res. 2024 Sep 30;38(3):212-221. doi: 10.4285/ctr.24.0031.
4
SARS-CoV-2 infection in solid organ transplant recipients: Experience with molnupiravir.严重急性呼吸综合征冠状病毒 2 感染实体器官移植受者：莫努匹韦的经验。
Rev Esp Quimioter. 2023 Nov;36 Suppl 1(Suppl 1):22-24. doi: 10.37201/req/s01.06.2023. Epub 2023 Nov 24.
Zotero 插件